LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 70

Search options

  1. Article ; Online: Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical Trials.

    de Viron, Sylviane / Trotta, Laura / Steijn, William / Young, Steve / Buyse, Marc

    Therapeutic innovation & regulatory science

    2024  Volume 58, Issue 3, Page(s) 483–494

    Abstract: Background: Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating emerging issues in the conduct of a clinical trial that may have an adverse impact on patient safety and/or the ... ...

    Abstract Background: Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating emerging issues in the conduct of a clinical trial that may have an adverse impact on patient safety and/or the reliability of trial results. This paper, focusing on statistical data monitoring (SDM), is the second of a series that attempts to quantify the impact of central monitoring in clinical trials.
    Material and methods: Quality improvement was assessed in studies using SDM from a single large central monitoring platform. The analysis focused on a total of 1111 sites that were identified as at-risk by the SDM tests and for which the study teams conducted a follow-up investigation. These sites were taken from 159 studies conducted by 23 different clinical development organizations (including both sponsor companies and contract research organizations). Two quality improvement metrics were assessed for each selected site, one based on a site data inconsistency score (DIS, overall -log
    Results: The SDM quality metrics showed improvement in 83% (95% CI, 80-85%) of the sites across therapeutic areas and study phases (primarily phases 2 and 3). In contrast, only 56% (95% CI, 41-70%) of sites showed improvement in 2 historical studies that did not use SDM during study conduct.
    Conclusion: The results of this analysis provide clear quantitative evidence supporting the hypothesis that the use of SDM in central monitoring is leading to improved quality in clinical trial conduct and associated data across participating sites.
    MeSH term(s) Humans ; Clinical Trials as Topic ; Data Accuracy ; Quality Improvement ; Clinical Trials Data Monitoring Committees ; Reproducibility of Results ; Patient Safety
    Language English
    Publishing date 2024-02-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2708397-4
    ISSN 2168-4804 ; 2168-4790
    ISSN (online) 2168-4804
    ISSN 2168-4790
    DOI 10.1007/s43441-024-00613-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Correction: Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials.

    Dirks, Abigail / Florez, Maria / Torche, Francois / Young, Steve / Slizgi, Brian / Getz, Kenneth

    Therapeutic innovation & regulatory science

    2024  

    Language English
    Publishing date 2024-04-30
    Publishing country Switzerland
    Document type Published Erratum
    ZDB-ID 2708397-4
    ISSN 2168-4804 ; 2168-4790
    ISSN (online) 2168-4804
    ISSN 2168-4790
    DOI 10.1007/s43441-024-00648-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Comprehensive Assessment of Risk-Based Quality Management Adoption in Clinical Trials.

    Dirks, Abigail / Florez, Maria / Torche, Francois / Young, Steve / Slizgi, Brian / Getz, Kenneth

    Therapeutic innovation & regulatory science

    2024  Volume 58, Issue 3, Page(s) 520–527

    Abstract: Background: Risk-based monitoring (RBM) and risk-based quality management (RBQM) offer a compelling approach to increase efficiency, speed and quality in clinical trials by prioritizing and mitigating risks related to essential safety and efficacy data. ...

    Abstract Background: Risk-based monitoring (RBM) and risk-based quality management (RBQM) offer a compelling approach to increase efficiency, speed and quality in clinical trials by prioritizing and mitigating risks related to essential safety and efficacy data. Since 2013, the FDA and EMA have encouraged the use of RBM/RBQM, however adoption has been slow with limited understanding of the barriers to adoption.
    Methods: The Tufts Center for the Study of Drug Development conducted an online survey among pharmaceutical, biotechnology, and contract research organizations and gathered 206 responses on 32 distinct RBQM practices.
    Results: On average, companies implemented RBQM in 57% of their clinical trials. Lower levels of adoption were observed among companies conducting fewer than 25 trials annually (48%) compared to those conducting more than 100 trials annually (63%). Primary barriers to adoption include lack of organizational knowledge and awareness, mixed perceptions of the value proposition of RBQM, and poor change management planning and execution. Insights into improving the level of adoption are discussed.
    MeSH term(s) Clinical Trials as Topic ; Humans ; Risk Management ; Surveys and Questionnaires ; United States ; Drug Industry
    Language English
    Publishing date 2024-02-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2708397-4
    ISSN 2168-4804 ; 2168-4790
    ISSN (online) 2168-4804
    ISSN 2168-4790
    DOI 10.1007/s43441-024-00618-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: An opportunity for Cinderella.

    Young, Steve

    British journal of community nursing

    2014  Volume Suppl, Page(s) S5

    MeSH term(s) Humans ; Length of Stay/statistics & numerical data ; Lymphedema/economics ; Lymphedema/nursing ; State Medicine/economics ; United Kingdom
    Language English
    Publishing date 2014-04
    Publishing country England
    Document type Editorial
    ZDB-ID 2146386-4
    ISSN 1462-4753
    ISSN 1462-4753
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Quality Tolerance Limits' Place in the Quality Management System and Link to the Statistical Trial Design: Case Studies and Recommendations from Early Adopters.

    Wolfs, Marion / Bojarski, Łukasz / Young, Steve / Cesario, Lynne / Makowski, Marcin / Sullivan, Linda B

    Therapeutic innovation & regulatory science

    2023  Volume 57, Issue 4, Page(s) 839–848

    Abstract: Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and suggest ways of implementing quality tolerance limits (QTLs) alongside existing risk-based quality management methodologies. While these efforts have ... ...

    Abstract Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and suggest ways of implementing quality tolerance limits (QTLs) alongside existing risk-based quality management methodologies. While these efforts have contributed positively to developing a common understanding of QTLs, some uncertainty remains regarding implementable approaches. In this article, we review the approaches taken by some leading biopharmaceutical companies, offering recommendations for how to make QTLs most effective, what makes them ineffective, and several case studies to illustrate these concepts. This includes how best to choose QTL parameters and thresholds for a given study, how to differentiate QTLs from key risk indicators, and how QTLs relate to critical-to-quality factors and the statistical design of the trials.
    MeSH term(s) Quantitative Trait Loci ; Risk Management ; Biological Products
    Chemical Substances Biological Products
    Language English
    Publishing date 2023-03-27
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2708397-4
    ISSN 2168-4804 ; 2168-4790
    ISSN (online) 2168-4804
    ISSN 2168-4790
    DOI 10.1007/s43441-023-00504-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Correction: Quality Tolerance Limits' Place in the Quality Management System and Link to the Statistical Trial Design: Case Studies and Recommendations from Early Adopters.

    Wolfs, Marion / Bojarski, Łukasz / Young, Steve / Cesario, Lynne / Makowski, Marcin / Sullivan, Linda B

    Therapeutic innovation & regulatory science

    2023  Volume 57, Issue 5, Page(s) 1121

    Language English
    Publishing date 2023-06-16
    Publishing country Switzerland
    Document type Published Erratum
    ZDB-ID 2708397-4
    ISSN 2168-4804 ; 2168-4790
    ISSN (online) 2168-4804
    ISSN 2168-4790
    DOI 10.1007/s43441-023-00546-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book ; Online: Nanoscale Architecture for Frequency-Resolving Single-Photon Detectors

    Young, Steve M. / Sarovar, Mohan / Léonard, François

    2022  

    Abstract: Single photon detectors play a key role across a number of basic science and technology applications. While progress has been made in improving performance, single photon detectors that can maintain high performance while also resolving the photon ... ...

    Abstract Single photon detectors play a key role across a number of basic science and technology applications. While progress has been made in improving performance, single photon detectors that can maintain high performance while also resolving the photon frequency are still lacking. Here we employ quantum dynamical simulations to show that a photodetector architecture composed of nanoscale elements that collectively interact with the photon field can simultaneously achieve high efficiency, low jitter, low dark count rate, and high frequency resolution. We discuss the factors that impact performance and trade-offs between metrics. Finally, a potential physical realization of such an architecture is presented.
    Keywords Quantum Physics ; Condensed Matter - Materials Science ; Physics - Optics
    Publishing date 2022-05-11
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Book ; Online: Optimal control of a cavity-mediated iSWAP gate between silicon spin qubits

    Young, Steve M. / Jacobson, N. Tobias / Petta, Jason R.

    2022  

    Abstract: Semiconductor spin qubits may be coupled through a superconducting cavity to generate an entangling two-qubit gate. However, the fidelity of such an operation will be reduced by a variety of error mechanisms such as charge and magnetic noise, phonons, ... ...

    Abstract Semiconductor spin qubits may be coupled through a superconducting cavity to generate an entangling two-qubit gate. However, the fidelity of such an operation will be reduced by a variety of error mechanisms such as charge and magnetic noise, phonons, cavity loss, transitions to non-qubit states and, for electrons in silicon, excitation into other valley eigenstates. Here, we model the effects of these error sources and the valley degree of freedom on the performance of a cavity-mediated two-qubit iSWAP gate. For valley splittings inadequately large relative to the interdot tunnel coupling within each qubit, we find that valley excitation may be a limiter to the fidelity of this two-qubit gate. In addition, we show tradeoffs between gating times and exposure to various error sources, identifying optimal operating regimes and device improvements that would have the greatest impact on the fidelity of the cavity-mediated spin iSWAP. Importantly, we find that while the impact of charge noise and phonon relaxation favor operation in the regime where the qubits are most spin-like to reduce sensitivity to these sources of noise, the combination of hyperfine noise and valley physics shifts the optimal regime to charge-like qubits with stronger effective spin-photon coupling so that gate times can be made as short as possible. In this regime, the primary limitation is the need to avoid Landau-Zener transitions as the gate is implemented.
    Keywords Condensed Matter - Mesoscale and Nanoscale Physics ; Condensed Matter - Materials Science
    Subject code 530
    Publishing date 2022-08-23
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes.

    de Viron, Sylviane / Trotta, Laura / Steijn, William / Young, Steve / Buyse, Marc

    Therapeutic innovation & regulatory science

    2022  Volume 57, Issue 2, Page(s) 295–303

    Abstract: Background: Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the quality of clinical research by pro-actively identifying and remediating emerging issues in the conduct of a clinical trial that may ... ...

    Abstract Background: Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the quality of clinical research by pro-actively identifying and remediating emerging issues in the conduct of a clinical trial that may have an adverse impact on patient safety and/or the reliability of trial results. However, there has to-date been a relative lack of direct quantitative evidence published supporting the claim that central monitoring actually leads to improved quality.
    Material and methods: Nine commonly used KRIs were analyzed for evidence of quality improvement using data retrieved from a large central monitoring platform. A total of 212 studies comprising 1676 sites with KRI signals were used in the analysis, representing central monitoring activity from 23 different sponsor organizations. Two quality improvement metrics were assessed for each KRI, one based on a statistical score (p-value) and the other based on a KRI's observed value.
    Results: Both KRI quality metrics showed improvement in a vast majority of sites (82.9% for statistical score, 81.1% for observed KRI value). Additionally, the statistical score and the observed KRI values improved, respectively by 66.1% and 72.4% on average towards the study average for those sites showing improvement.
    Conclusion: The results of this analysis provide clear quantitative evidence supporting the hypothesis that use of KRIs in central monitoring is leading to improved quality in clinical trial conduct and associated data across participating sites.
    MeSH term(s) Humans ; Reproducibility of Results ; Benchmarking
    Language English
    Publishing date 2022-10-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2708397-4
    ISSN 2168-4804 ; 2168-4790
    ISSN (online) 2168-4804
    ISSN 2168-4790
    DOI 10.1007/s43441-022-00470-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Self- vs provider-referral differences for coronary artery calcium testing.

    Lantz, Rebekah / Young, Steve / Lubov, Janet / Ahmed, Anas / Markert, Ronald / Sadhu, Srikanth

    American heart journal plus : cardiology research and practice

    2022  Volume 13, Page(s) 100088

    Abstract: Study objectives: The objectives of this study were to identify independent predictors for moderate/accentuated coronary artery calcium (CAC) score and compare patients who self-referred for CAC Computed Tomography (CT) testing to those who were ... ...

    Abstract Study objectives: The objectives of this study were to identify independent predictors for moderate/accentuated coronary artery calcium (CAC) score and compare patients who self-referred for CAC Computed Tomography (CT) testing to those who were provider-referred.
    Design: Patients underwent CAC between January to July 2019. The analysis was divided into self-referred patients influenced by a CAC community campaign who identified themselves as having cardiovascular risk factors compared to provider-referred intermediate-risk patients who were asymptomatic. SAS version 9.4 (SAS Institute, Inc., Cary, NC) was used for all analyses.
    Setting: Seven southwest Ohio hospitals from a single network.
    Participants: 2124 adult patients who received CAC CT (163 self and 1961 provider-referred).
    Interventions: CAC CT.
    Main outcome measures: Demographics, risk factors, lab values, prescriptions, and referral status were used to compare CAC score differences between self- and provider-referred patients.
    Results: For 2124 patients, three predictors for moderate/accentuated CAC score remained significant after multiple logistic regression: CKD (OR 0.24, CI 0.008-0.68,
    Conclusions: CAC CT testing is associated with independent risk predictors and can be used to clarify cardiovascular risk in self- and provider-referred patients with statistical similarity. Patients reliably self-refer for CAC CT when risk is present during a community initiative. Such initiatives may have a preventive benefit and lead to earlier pursuit and optimization of anti-lipid therapies.
    Language English
    Publishing date 2022-02-01
    Publishing country United States
    Document type Journal Article
    ISSN 2666-6022
    ISSN (online) 2666-6022
    DOI 10.1016/j.ahjo.2022.100088
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top